Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
10/2003
10/23/2003US20030199454 Sulfonimide (substituted) acyl dipeptidyl interleukin-1 beta converting enzyme (ICE)/cell death gene (ced) enzyme inhibitor compounds as anitinflammatory agents, for autoimmune and neurogenerative diseases
10/23/2003CA2481202A1 Functionalized ionic liquids, and methods of use thereof
10/22/2003EP1354871A1 Biphenyl derivatives
10/22/2003EP1354214A2 Mri method involving the use of a hyperpolarized contrast agent
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/22/2003EP1183236B1 Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives
10/22/2003EP0699069B9 Endothelin receptor antagonists
10/22/2003CN1450989A 7-substituted tetracycline compounds
10/22/2003CN1450053A Ternary sulfonimine transition metal salt and synthesis method thereof
10/22/2003CN1450052A Ternary sulfonimine alkali salt and synthesis method thereof
10/22/2003CN1125061C C2 taxane derivatives and pharmaceutical compositions containing them
10/22/2003CN1125044C Novel prostaglandin synthase inhibitors
10/22/2003CN1124846C (N.N')-bis (sulfonyl) hydrazines useful as antineoplastic agents
10/21/2003US6635786 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
10/21/2003US6635783 Bicyclic 1,3-aminoalcohols, d8-metal complexes and hydrogenation processes
10/21/2003US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors
10/21/2003CA2103894C Aryl sulphonyl urea compounds, a method of preparing them, and their use as herbicides and growth regulators
10/21/2003CA2098020C Anti-viral compounds
10/21/2003CA2060326C Antiarrhythmic tertiary amine-alkenyl-phenyl-alkanesulfonamides
10/16/2003WO2003084917A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003WO2003084525A1 Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases
10/16/2003WO2003084303A2 Antagonists of rf-amide neuropeptides
10/16/2003WO2002083608A3 Methods of preparing sulfinamide and sulfoxides
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030195332 PNA monomer and precursor
10/16/2003US20030195269 Ionic compounds with delocalized anionic charge, and their use as ion conducting components or as catalysts
10/16/2003US20030195229 Administering viricides such as N-nonenyl glucosamine, and optionally with mixtures of nucleosides, nucleotides, immunomodulators or immunostimulants for prophylaxis viral diseases
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030195159 HIV protease inhibitors based on amino acid derivatives
10/16/2003US20030194748 Method for labeling with tritium
10/16/2003CA2481035A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003CA2480697A1 Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases
10/15/2003EP1352900A1 Process to prepare taxol
10/15/2003EP1352899A1 Process to prepare taxol
10/15/2003EP1351959A1 Novel pleuromutilin derivatives
10/15/2003EP1351933A1 Il-8 receptor antagonists
10/15/2003EP1351928A2 Novel n(phenylsulphonyl)glycine derivatives and their therapeutic use
10/15/2003EP0766674B1 New hiv protease inhibitors
10/15/2003CN1449380A Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
10/14/2003US6632840 Monoacyl-substituted guanidines, a process for their preparation, their use as a medicament or diagnostic aid, and pharmaceutical compositions containing them
10/14/2003US6632838 Use of bissulfonamides for producing medicines for the treatment of hyperlipidemia
10/14/2003US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like
10/14/2003US6632816 Aromatic derivatives as HIV aspartyl protease inhibitors
10/14/2003US6632815 Show selectivity for factor Xa versus other proteases of coagulation or the fibrinolytic cascades
10/09/2003WO2003083063A2 Common ligand mimics: naphtoates
10/09/2003WO2003082777A2 Novel glucocorticoid receptor ligands
10/09/2003WO2003082205A2 Compounds and methods
10/09/2003WO2002009686A3 Cdc25 phosphatase inhibitors
10/09/2003US20030191345 Catalysts, methods for making said catalysts, and methods for making chiral compounds with high enantioselectivity
10/09/2003US20030191341 Chemical process
10/09/2003US20030191323 An acylsulfonamide derivatives having insulin resistance, used as enzyme inhibitor of acetyl CoA carboxylase, preventing and curing diabetes
10/09/2003US20030191319 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/09/2003US20030191317 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
10/09/2003US20030191309 Administering N-substituted arylsulfonylamino hydroxamic acids to a patient for the treatment of arthritis and hepatic cirrhosis
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003US20030190298 Use as skin lightening agents
10/08/2003EP1349847A1 Oxybenzamides derivatives as factor xa inhibitors
10/08/2003EP0882707B1 Novel tricyclic compounds and drug compositions containing the same
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/08/2003CN1123564C Anti-inflammatory compounds
10/07/2003US6630600 Intermediate for their manufacture, pharmaceutical preparations containing them and the use of the compounds in clinical conditions associated with insulin resistance.
10/07/2003US6630513 Capable of lowering plasma cholesterol levels and inhibiting abnormal cell proliferation, such as in cervical adenocarcinoma
10/07/2003US6630512 Cell adhesion inhibitors
10/07/2003US6630503 Cell adhesion inhibitors
10/02/2003WO2003080556A1 Amine derivative with potassium channel regulatory function, its preparation and use
10/02/2003WO2003080042A1 Decomposition inhibitor for extracellular matrix of cartilage
10/02/2003WO2003080041A1 Remedies for arthritis deformans
10/02/2003WO2003080038A1 Preventive or therapeutic agent for kidney disease
10/02/2003WO2003079984A2 Substituted tetracycline compounds
10/02/2003US20030187276 Hydrophobic polyamine analogs and methods for their use
10/02/2003US20030187233 Perfluoroisopropybenzene derivative
10/02/2003US20030187065 Hypoglycemic agents; antidiabetic agents
10/02/2003US20030187037 Cardiovascular disorders; antiinflammatory agents; antitumor agents
10/02/2003US20030187035 Substituted hydrazones as inhibitors of cyclooxygenase-2
10/02/2003US20030187033 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents
10/02/2003US20030186944 Novel aromatic compounds
10/02/2003US20030185880 Glyburidge composition
10/02/2003CA2479254A1 Preventive or therapeutic agent for renal disease
10/01/2003EP1347938A1 Method for fluorinating a compound comprising a halosulphonyl or dihalophosphonyl group
10/01/2003EP1202724B1 Method for treating chronic pain using mek inhibitors
10/01/2003EP1084102B1 New 3-aryl propionic acid derivatives and analogs
10/01/2003EP0928287B1 Ionic compounds with delocalized anionic charge, their use as components of ionic conductors or catalyst
10/01/2003CN1445213A Method for synthesizing arylamine compound
10/01/2003CN1122662C Arylsulfonylamino hydroxamic acid derivatives
09/2003
09/30/2003US6627767 Controlling cellular metabolism
09/30/2003US6627656 Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore
09/30/2003US6627399 Using compound of given formula as accelerator
09/30/2003US6627099 Electrolyte composition and electrochemical battery using the same
09/25/2003WO2003078438A1 Carbamates as hiv protease inhibitors
09/25/2003WO2003077847A2 Substituted amides
09/25/2003WO2003077828A2 Novel florfenicol-type antibiotics
09/25/2003WO2003029199A9 Benzene derivatives, process for preparing the same and use thereof
09/25/2003US20030181766 Amidino derivatives, and anticoagulants and thrombosis therapeutic agents containing them
09/25/2003US20030181764 Acylsulfonamide derivatives containing fluorosubstitutedphenylethynyl group having a hypoglycemic effect and free of the side effect
09/25/2003US20030181726 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
09/25/2003US20030181723 Preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-P-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines
09/25/2003US20030181490 For therapy and prophylaxis of acquired immune deficiency syndrome (AIDS), or ARC
09/25/2003US20030181442 Carbamides such as N-(3-tert-butylphenyl)-N'-(4-(3-(N-methyl-carbamoyl)phenoxy)phenyl urea, used as enzyme inhibitors and as anticarcinogenic agents
09/25/2003US20030180236 Resorcinol derivatives
09/25/2003CA2478731A1 Carbamates as hiv protease inhibitors
1 ... 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 ... 177